The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
NABNEC: A randomised phase II study of nab-paclitaxel in combination with carboplatin as first line treatment of gastrointestinal neuroendocrine carcinomas (GI-NECs).
 
Lorraine A. Chantrill
Honoraria - Amgen; Amgen; Merck; SERVIER
 
David Ransom
Travel, Accommodations, Expenses - Ipsen
 
David Chan
Honoraria - Camurus (Inst)
 
Adnan Nagrial
Stock and Other Ownership Interests - Bristol-Myers Squibb/Celgene
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; MSD Oncology
Research Funding - Akeso Biopharma (Inst); Amgen (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); MSD Oncology (Inst)
 
Nick Pavlakis
Consulting or Advisory Role - Amgen; AstraZeneca; Beigene; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; Merck KGaA; Merck Serono; Merck Sharp & Dohme; Novartis; Pfizer; Roche; Takeda
Research Funding - Bayer (Inst); Pfizer (Inst); Roche (Inst)
 
Ben Markman
Consulting or Advisory Role - Amgen; AstraZeneca; BeiGene; Bristol-Myers Squibb; Merck
 
Christos Stelios Karapetis
Honoraria - AstraZeneca; BMS; Janssen; MSD; Roche
Consulting or Advisory Role - AstraZeneca; Bayer; BeiGene; Bristol-Myers Squibb; Eisai; Ipsen; Lilly; Merck Serono; Pierre Fabre; Roche; Takeda
 
Katrin Marie Sjoquist
Honoraria - BMS; Merck; MSD; Novotech (Inst); Novotech (Inst); SERVIER
Research Funding - Bayer (Inst)
Other Relationship - Novotech
 
John Simes
Consulting or Advisory Role - FivePhusion (Inst)
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); MSD (Inst); Pfizer (Inst); Roche (Inst)
 
Val Gebski
No Relationships to Disclose
 
Michael S Hofman
Consulting or Advisory Role - Janssen; POINT Biopharma
Speakers' Bureau - Astellas Pharma; AstraZeneca; Janssen; Mundipharma
Research Funding - Bayer (Inst); Isotopia (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Genzyme; Ipsen; Janssen; Novartis
 
Pablo Gonzalez Ginestet
No Relationships to Disclose
 
Anthony J. Gill
No Relationships to Disclose
 
Sonia Yip
No Relationships to Disclose
 
Michael Michael
Honoraria - Novartis; SAM NORDIC
Consulting or Advisory Role - Ipsen; Isotopen Technologien; MDS; Merck; PanTher Therapeutics
Research Funding - Ipsen
Travel, Accommodations, Expenses - Ipsen; Ipsen; Novartis
 
Anthony Jaworski
No Relationships to Disclose
 
Ho Wai Derrick Siu
No Relationships to Disclose
 
Mustafa Khasraw
Honoraria - Novartis; Pfizer
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; George Clincal; Janssen; Lilly; Novocure; Roche; SERVIER; Stemline Therapeutics; Voyager Therapeutics
Research Funding - Abbvie (Inst); Astex Pharmaceuticals (Inst); BioNTech SE (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); cns pharmaceuticals (Inst); daiichi Sankyo (Inst); Immorna (Inst); Immvira (Inst); Personalis (Inst); Specialised Therapeutics (Inst)
Travel, Accommodations, Expenses - Roche/Genentech